Presale: Fosse Master Issuer PLC (Series 2012-1) May 12

  • ID: 2127511
  • May 2012
  • Standard & Poors
1 of 3


  • Fosse Master Issuer PLC
  • Santander UK PLC
  • MORE

Standard & Poor's Ratings Services has assigned preliminary credit ratings to Fosse Master Issuer PLC's mortgage-backed notes series 2012-1. In addition, Fosse Master Issuer will issue subordinated unrated class Z notes. The general reserve fund will decrease in percentage terms to 3.48% from 3.61% prior to the 2012-1 issuance. Overall credit enhancement will be 19.10% for the class A notes, as further class Z notes will be issued. On the closing date, Fosse will purchase additional collateral in connection with this transaction. A pool of first-ranking mortgages secured over properties in England, Scotland, Wales, and Northern Ireland will collateralize the notes. Alliance & Leicester PLC (whose assets and liabilities Santander UK PLC assumed in May 2010) historically originated all of...

Companies mentioned in this report are:
- Santander UK PLC
- Fosse Master Issuer PLC

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research Type: Full Analysis

Note: Product cover images may vary from those shown
2 of 3

- Santander UK PLC
- Fosse Master Issuer PLC

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown


  • Quick Help: This Credit Rating Report will be emailed to you.


If you have a more general question about our products please try our



Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer, Inc.